English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  52201616    ???header.onlineuser??? :  1100
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"lin zz"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-9 of 9  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-09-08T07:32:27Z The Long-Term and Mediating Effects of Mindfulness Integrated with Body-Mind-Spirit Group Therapy on Depressive Symptoms and Quality of Life Among Non-small Cell Lung Cancer Patients Hsiao, FH; Lin, ZZ; Huang, FY; Lai, YM; Chen, YT; Shih, JY; CHAO-CHI HO; Yu, CJ; Hsieh, CC
國家衛生研究院 2014-07 Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer Shen, YC;Li, CP;Yen, CJ;Hsu, C;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Yeh, KH;Cheng, AL
臺北醫學大學 2013 The Aurora Kinases Inhibitor VE-465 is a Novel Treatment for Glioblastoma Multiforme Lee, PY;Chen, CL;Lin, ZZ;Cheng, AL;Chen, IT;Jacqueline, Whang-Peng;Huang, CY
國家衛生研究院 2011-09 Phase II study of low-dose everolimus plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for first-line treatment of metastatic or recurrent gastric cancers Yeh, K;Shen, YC;Li, CP;Yen, CJ;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Cheng, AL
國家衛生研究院 2010-04 A Randomized, Double-blind, Parallel, Comparative Study to Evaluate the Efficacy and Safety of Ramosetron plus Dexamethasone Injection for the Prevention of Acute Chemotherapy-induced Nausea and Vomiting Ho, CL;Su, WC;Hsieh, RK;Lin, ZZ;Chao, TY
國立臺灣大學 2009-03 The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma. Lin, ZZ; Hsu, HC; Hsu, CH; Yeh, PY; Huang, CY; Huang, YF; Chen, TJ; Kuo, SH; Hsu, C; Hu, FC; Jeng, YM; Chung, Y; Cheng, AL.
國家衛生研究院 2009-02 Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival Shen, YC;Hu, FC;Jeng, YM;Chang, YT;Lin, ZZ;Chang, MC;Hsu, C;Cheng, AL
國立臺灣大學 2008-06 Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy. Yang, CH; Yu, CJ; Shih, JY; Chang, YC; Hu, FC; Tsai, MC; Chen, KY; Lin, ZZ; Huang, CJ; Shun, CT; Huang, CL; Bean, J; Cheng, AL; Pao, W; Yang, PC.
高雄醫學大學 2008 High efficacy of erlotinib in Taiwanese NSCLC patients in an exp;ed access program study previously treated with chemotherapy  黃明賢; Perng RP;Yang CH;Chen YM;Chang GC;Lin MC;Hsieh RK;Chu NM;Lai RS;Su WC;Tsao CJ;Hsia TC;Chen HC;Chen CH;Huang MS;Wang JL;Ho ML;Chung CY;Yu CJ;Chang WC;Kuo HP;Yu CT;Lin ZZ;Kao WY. 

Showing items 1-9 of 9  (1 Page(s) Totally)
1 
View [10|25|50] records per page